UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study

Blood, 2015-06, Vol.125 (25), p.3956-3962

2015

Volltextzugriff (PDF)

Asymmetric Organocatalytic One-Pot, Two-Step Sequential Process to Synthesize Chiral Acetal-Containing Polycyclic Derivatives from Cyclic Hemiacetals and Enones

Journal of organic chemistry, 2017-10, Vol.82 (19), p.10450-10460

2017

Volltextzugriff (PDF)

Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients

Journal of hematology and oncology, 2019-09, Vol.12 (1), p.88-9, Article 88

2019

Volltextzugriff (PDF)

Who is the best donor for a related HLA haplotype-mismatched transplant?

Blood, 2014-08, Vol.124 (6), p.843-850

2014

Volltextzugriff (PDF)

Risk stratification–directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation

Blood, 2012-04, Vol.119 (14), p.3256-3262

2012

Volltextzugriff (PDF)

Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis

Journal of hematology and oncology, 2017-07, Vol.10 (1), p.134-134, Article 134

2017

Volltextzugriff (PDF)

Asymmetric organocatalytic vinylogous Michael addition triggered triple-cascade reactions of 2-hydroxycinnamaldehydes and vinylogous nucleophiles: construction of benzofused oxabicyclo[3.3.1]nonane scaffolds

Chemical communications (Cambridge, England), 2021-02, Vol.57 (14), p.1762-1765

2021

Volltextzugriff (PDF)

Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized study

Journal of hematology and oncology, 2020-03, Vol.13 (1), p.27-27, Article 27

2020

Volltextzugriff (PDF)

Adoptive therapy with cytomegalovirus‐specific T cells for cytomegalovirus infection after haploidentical stem cell transplantation and factors affecting efficacy

American journal of hematology, 2022-06, Vol.97 (6), p.762-769

2022

Volltextzugriff (PDF)

Asymmetric iminium ion-catalyzed conjugate addition of 2-hydroxycinnamaldehydes and 2-oxocarboxylic esters: synthesis of chiral polysubstituted bridged bicyclic ketals

Chemical communications (Cambridge, England), 2023-07, Vol.59 (56), p.8711-8714

2023

Volltextzugriff (PDF)

Long-Term Follow-Up of Haploidentical Hematopoietic Stem Cell Transplantation Without In Vitro T Cell Depletion for the Treatment of Leukemia: Nine Years of Experience at a Single Center

Cancer, 2013-03, Vol.119 (5), p.978-985

2013

Volltextzugriff (PDF)

Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibody

Bone marrow transplantation (Basingstoke), 2020-07, Vol.55 (7), p.1326-1336

2020

Volltextzugriff (PDF)

Diversity-Oriented One-Pot Synthesis to Construct Functionalized Chroman-2-one Derivatives and Other Heterocyclic Compounds

Journal of organic chemistry, 2017-05, Vol.82 (9), p.4774-4783

2017

Volltextzugriff (PDF)

Minimal residual disease status determined by multiparametric flow cytometry pretransplantation predicts the outcome of patients with ALL receiving unmanipulated haploidentical allografts

American journal of hematology, 2019-05, Vol.94 (5), p.512-521

2019

Volltextzugriff (PDF)

Asymmetric organocatalytic multicomponent reactions for efficient construction of bicyclic compounds bearing bisacetal and isoxazolidine moieties

Chemical communications (Cambridge, England), 2020-10, Vol.56 (84), p.12765-12768

2020

Volltextzugriff (PDF)

Prognostic factors and long‐term follow‐up of basiliximab for steroid‐refractory acute graft‐versus‐host disease: Updated experience from a large‐scale study

American journal of hematology, 2020-08, Vol.95 (8), p.927-936

2020

Volltextzugriff (PDF)

MAGE genes: Prognostic indicators in AL amyloidosis patients

Journal of cellular and molecular medicine, 2019-08, Vol.23 (8), p.5672-5678

2019

Volltextzugriff (PDF)

Optimal dose of rabbit thymoglobulin in conditioning regimens for unmanipulated, haploidentical, hematopoietic stem cell transplantation: Long‐term outcomes of a prospective randomized trial

Cancer, 2017-08, Vol.123 (15), p.2881-2892

2017

Volltextzugriff (PDF)

Haploidentical hematopoietic stem cell transplantation with busulfan, cyclophosphamide, and fludarabine conditioning for X‐linked adrenal cerebral leukodystrophy

Pediatric transplantation, 2024-05, Vol.28 (3), p.e14735-n/a

2024

Volltextzugriff (PDF)

Long‐term follow‐up of haploidentical haematopoietic stem cell transplantation in paediatric patients with high‐risk acute myeloid leukaemia: Report from a single centre

British journal of haematology, 2024-02, Vol.204 (2), p.585-594

2024

Volltextzugriff (PDF)

An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective study

Blood, 2022-08, Vol.140 (5), p.516-520

2022

Volltextzugriff (PDF)

Dynamic immune profiling identifies the stronger graft-versus-leukemia (GVL) effects with haploidentical allografts compared to HLA-matched stem cell transplantation

Cellular & molecular immunology, 2021-05, Vol.18 (5), p.1172-1185

2021

Volltextzugriff (PDF)

Different hybridized oxygen atoms controlled chemoselective formation of oxocarbenium ions: synthesis of chiral heterocyclic compounds

Organic & biomolecular chemistry, 2018, Vol.16 (35), p.6507-6520

2018

Volltextzugriff (PDF)

Prophylactic NAC promoted hematopoietic reconstitution by improving endothelial cells after haploidentical HSCT: a phase 3, open-label randomized trial

BMC medicine, 2022-04, Vol.20 (1), p.140-13, Article 140

2022

Volltextzugriff (PDF)

Donor activating killer cell immunoglobulin‐like receptors genes correlated with Epstein–Barr virus reactivation after haploidentical haematopoietic stem cell transplantation

British journal of haematology, 2022-02, Vol.196 (4), p.1007-1017

2022

Volltextzugriff (PDF)

1 – 25 von 1.620

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.219)
Mit Volltextzugriff
(1.409)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.367)
Chinesisch
(246)
Japanisch
(3)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(976)
Life Sciences & Biomedicine
(557)
Humans
(439)
Male
(334)
Female
(321)
Physical Sciences
(321)
Adult
(285)
Technology
(269)
Middle Aged
(264)
Adolescent
(235)
Chemistry
(234)
Hematology
(192)
Young Adult
(172)
Child
(163)
Materials Science
(139)
Oncology
(136)
Hematopoietic Stem Cell Transplantation
(133)
Retrospective Studies
(119)
Transplantation
(114)
Transplantation, Homologous
(112)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(72)
中华血液学杂志
(63)
Zhōnghuá Xuèyèxué Zázhì
(61)
中华医学杂志
(49)
Biology Of Blood And Marrow Transplantation
(41)
Chinese Medical Journal
(38)
Zhong Hua Yi Xue Za Zhi
(29)
Annals Of Hematology
(25)
Cheminform
(25)
Chung-Hua Nei Kʿo Tsa Chih
(23)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study

Asymmetric Organocatalytic One-Pot, Two-Step Sequential Process to Synthesize Chiral Acetal-Containing Polycyclic Derivatives from Cyclic Hemiacetals and Enones

Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients

Who is the best donor for a related HLA haplotype-mismatched transplant?

Risk stratification–directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation

Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis

Asymmetric organocatalytic vinylogous Michael addition triggered triple-cascade reactions of 2-hydroxycinnamaldehydes and vinylogous nucleophiles: construction of benzofused oxabicyclo[3.3.1]nonane scaffolds

Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized study

Adoptive therapy with cytomegalovirus‐specific T cells for cytomegalovirus infection after haploidentical stem cell transplantation and factors affecting efficacy

Asymmetric iminium ion-catalyzed conjugate addition of 2-hydroxycinnamaldehydes and 2-oxocarboxylic esters: synthesis of chiral polysubstituted bridged bicyclic ketals

Long-Term Follow-Up of Haploidentical Hematopoietic Stem Cell Transplantation Without In Vitro T Cell Depletion for the Treatment of Leukemia: Nine Years of Experience at a Single Center

Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibody

Diversity-Oriented One-Pot Synthesis to Construct Functionalized Chroman-2-one Derivatives and Other Heterocyclic Compounds

Minimal residual disease status determined by multiparametric flow cytometry pretransplantation predicts the outcome of patients with ALL receiving unmanipulated haploidentical allografts

Asymmetric organocatalytic multicomponent reactions for efficient construction of bicyclic compounds bearing bisacetal and isoxazolidine moieties

Prognostic factors and long‐term follow‐up of basiliximab for steroid‐refractory acute graft‐versus‐host disease: Updated experience from a large‐scale study

MAGE genes: Prognostic indicators in AL amyloidosis patients

Optimal dose of rabbit thymoglobulin in conditioning regimens for unmanipulated, haploidentical, hematopoietic stem cell transplantation: Long‐term outcomes of a prospective randomized trial

Haploidentical hematopoietic stem cell transplantation with busulfan, cyclophosphamide, and fludarabine conditioning for X‐linked adrenal cerebral leukodystrophy

Long‐term follow‐up of haploidentical haematopoietic stem cell transplantation in paediatric patients with high‐risk acute myeloid leukaemia: Report from a single centre

An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective study

Dynamic immune profiling identifies the stronger graft-versus-leukemia (GVL) effects with haploidentical allografts compared to HLA-matched stem cell transplantation

Different hybridized oxygen atoms controlled chemoselective formation of oxocarbenium ions: synthesis of chiral heterocyclic compounds

Prophylactic NAC promoted hematopoietic reconstitution by improving endothelial cells after haploidentical HSCT: a phase 3, open-label randomized trial

Donor activating killer cell immunoglobulin‐like receptors genes correlated with Epstein–Barr virus reactivation after haploidentical haematopoietic stem cell transplantation

Suchergebnisse filtern